These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8371615)

  • 41. Artificial liver support.
    Sussman NL; Kelly JH
    Clin Invest Med; 1996 Oct; 19(5):393-9. PubMed ID: 8889280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can Patients Who Develop Cerebral Death in Fulminant Liver Failure Despite Liver Transplantation Be Previously Forseen?
    Sarici KB; Karakas S; Otan E; Ince V; Koc C; Koc S; Bayraktar H; Aydin C; Kayaalp C; Gungor S; Kablan Y; Yilmaz S
    Transplant Proc; 2017 Apr; 49(3):571-574. PubMed ID: 28340835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of fulminant hepatic failure in children--an analysis of 56 cases.
    Devictor D; Tahiri C; Rousset A; Massenavette B; Russo M; Huault G
    Crit Care Med; 1993 Sep; 21(9 Suppl):S348-9. PubMed ID: 8365219
    [No Abstract]   [Full Text] [Related]  

  • 45. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure.
    Marcos A; Ham JM; Fisher RA; Olzinski AT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Posner MP
    Transplantation; 2000 May; 69(10):2202-5. PubMed ID: 10852626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatic encephalopathy in fulminant liver failure. Clinical aspects and therapeutic approaches].
    Bode JC
    Z Gastroenterol Verh; 1991 Mar; 26():10-3. PubMed ID: 1714112
    [No Abstract]   [Full Text] [Related]  

  • 47. Liver transplantation for fulminant hepatic failure.
    Lidofsky SD
    Gastroenterol Clin North Am; 1993 Jun; 22(2):257-69. PubMed ID: 8509170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Conservative therapy of liver failure].
    Strohmeyer G; Lenzen R
    Zentralbl Chir; 1992; 117(12):658-62. PubMed ID: 1285472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible.
    Abou-Assi S; Vlahcevic ZR
    Postgrad Med; 2001 Feb; 109(2):52-4, 57-60, 63-5 passim. PubMed ID: 11272694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of support systems used in the management of fulminant hepatic failure.
    McGuire BM; Sielaff TD; Nyberg SL; Hu MY; Cerra FB; Bloomer JR
    Dig Dis; 1995; 13(6):379-88. PubMed ID: 8590524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver assist devices (LADs) will not be used to treat fulminant hepatic failure (FHF), but its consequences, namely hepatic encephalopathy (HE).
    Sussman NL; Kelly JH
    Artif Organs; 1993 Jan; 17(1):43-5. PubMed ID: 8422234
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute liver failure: current hepatological-surgical therapy results].
    Lauchart W
    Schweiz Rundsch Med Prax; 1992 Jun; 81(24):802-3. PubMed ID: 1604098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Living-related donor liver transplantation for children with fulminant hepatic failure in Israel.
    Shouval DS; Mor E; Avitzur Y; Shamir R; Bar-Nathan N; Steinberg R; Schoenfeld T; Ben-Ari Z; Shapiro R
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):451-5. PubMed ID: 19322055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.
    Izumi S; Langley PG; Wendon J; Ellis AJ; Pernambuco RB; Hughes RD; Williams R
    Hepatology; 1996 Jun; 23(6):1507-11. PubMed ID: 8675171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation for childhood liver disease: an overview.
    Balistreri WF
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S18-23. PubMed ID: 9742490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver transplantation for fulminant hepatic failure and late-onset hepatic failure in children.
    Tan KC; Mondragon RS; Vougas V; Mieli-Vergani G; Heaton ND; Mowat AP; Chiyende J; Baker A; Koukoulis G; Portmann B
    Br J Surg; 1992 Nov; 79(11):1192-4. PubMed ID: 1467903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of acute and fulminant hepatitis A.
    O'Grady J
    Vaccine; 1992; 10 Suppl 1():S21-3. PubMed ID: 1476000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged artificial liver support in a child with fulminant hepatic failure.
    Okamoto K; Kurose M; Ikuta Y; Ogata K; Harada T; Takeda K; Sato T
    ASAIO J; 1996; 42(3):233-5. PubMed ID: 8725697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation.
    Hwang S; Lee SG; Park JI; Song GW; Ryu JH; Jung DH; Hwang GS; Jeong SM; Song JG; Hong SK; Lim YS; Kim KM
    Clin Transplant; 2010; 24(1):91-7. PubMed ID: 19925461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.